Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06142435 · ClinicalTrials.gov registry record
mTBI Identification and Monitoring Through Retinal Scanning
A clinical trial of Brain Injuries, Traumatic, sponsored by Rebiscan.
- Recruiting
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT06142435: Recruiting study of Brain Injuries, Traumatic, sponsored by Rebiscan.
NCT06142435 is a study of Brain Injuries, Traumatic that is actively recruiting participants, run by Rebiscan. The registered enrollment target is 60 participants, below the 253-participant average among 21 other Brain Injuries, Traumatic trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06142435, a study of Brain Injuries, Traumatic, is actively recruiting participants, sponsored by Rebiscan.
- RECRUITING
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Rebion has developed a device, the Rebion trauma tool (referred to as the head and intraocular trauma tool, or "HITT"), that detects ocular fixation and alignment using a binocular retinal scan. Preliminary data obtained from hospitalized patients with a clinically-confirmed traumatic brain injury (TBI) and uninjured controls indicates that the device can detect changes in ocular fixation, alignment, and saccades that are related to brain injury. This study seeks to evaluate the ability of the Rebion trauma tool to assess perturbations in eye movements resulting from TBI. The study will enroll 60 TBI patients and 20 controls.
Primary Outcome
Patients who present with suspected TBI to the clinic will have their eyes scanned to identify whether the HITT device can accurately identify patients with TBI.
Conditions Studied
Interventions
- DEVICE Head and Intraocular Trauma Tool
Study Locations (1)
Massachusetts
- Boston Medical Center Concussion Clinic, Ryan Center for Sports Medicine & Rehabilitation at Boston University - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2023-08-15 |
| Est. Completion | 2025-08-31 |
What NCT06142435 shows while recruiting
NCT06142435 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 253-participant average among 21 other Brain Injuries, Traumatic trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Brain Injuries, Traumatic appearing as the primary indexed condition, and to 1 intervention - of which Head and Intraocular Trauma Tool is the first listed.
NCT06142435 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06142435 about?
NCT06142435 is a clinical study titled "mTBI Identification and Monitoring Through Retinal Scanning". Rebion has developed a device, the Rebion trauma tool (referred to as the head and intraocular trauma tool, or "HITT"), that detects ocular fixation and alignment using a binocular retinal scan. Preliminary data obtained from hospitalized patients with a clinically-confirmed traumatic brain injury (...
What is the current status of trial NCT06142435?
This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2023-08-15. Estimated completion is 2025-08-31.
What conditions does trial NCT06142435 study?
This clinical trial studies the following conditions: Brain Injuries, Traumatic.
What interventions are being tested in trial NCT06142435?
The interventions under investigation include: Head and Intraocular Trauma Tool (DEVICE).
Who is sponsoring clinical trial NCT06142435?
This trial is sponsored by Rebiscan, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06142435 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Injuries, Traumatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06142435's enrollment target sits among peer trials
60 16th of 21 higher than 6 of 21 other Brain Injuries, Traumatic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Brain Injuries, Traumatic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Morning Bright Light to Improve Sleep Quality in Veterans
RECRUITING · NA
-
Automated Robotic TCD in Traumatic Brain Injury
RECRUITING
-
Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)
RECRUITING · NA
-
Brain Oxygen Optimization in Severe TBI, Phase 3
RECRUITING · NA
-
Buspirone and Melatonin for Depression Following Traumatic Brain Injury
RECRUITING · Phase 4
-
NEUROBALANCE Training to Improve Postural Control in Individuals With Traumatic Brain Injury
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI